A Parent’s Story: Our 16-Year-Old Son With Autism Age: 16 years Country: United Kingdom Diagnosis: Autism Spectrum Disorder (ASD) Regenerative cell therapy at Stem Plus Clinic: February 2026 Treatment duration: 4 days Our son is 16 years old, and we live in the United Kingdom. Our journey with regenerative cell therapy did not begin recently. […]
A Father’s Story: My 5-Year-Old Son With Autism Age: 5 years Country: Ireland Diagnosis: Autism Spectrum Disorder (ASD) Regenerative cell therapy: January 2026 We live in Ireland, and our son is now 5 years old. Before the therapy, our biggest concerns were his speech, limited eye contact, and difficulties interacting with other people. It has […]
A Mother’s Story: Our 8-Year-Old Son From Ireland Age: 8 years Country: Ireland Diagnosis: Autism Spectrum Disorder (ASD) First treatment: December 2025 Second treatment: June 2026 When we first came to StemPlus, our son was 8 years old. One of our biggest concerns was his extreme sensory sensitivity. Loud sounds could cause sudden panic and […]
A Mother’s Story: Our 6-Year-Old Son With Autism Age: 6 years Diagnosis: Autism Spectrum Disorder (ASD) Previous cell therapy: Mexico Treatment at StemPlus: January 2026 Cell type: MUSE cells Our son is 6 years old and has autism spectrum disorder. One of our biggest challenges was his behavior. He experienced episodes of severe aggression, which […]
A Mother’s Story: My 10-Year-Old Son With Autism Age: 10 years Diagnosis: Autism Spectrum Disorder (ASD) Regenerative cell therapy: November 2025 My son is 10 years old and has autism spectrum disorder. For years, our biggest challenges have been communication, attention, social interaction, and adapting to changes in everyday life. Before treatment, he used only […]
Who conducted the study and which universities were involved The main work was carried out at the Royan Institute for Stem Cell Biology and Technology (ACECR), Tehran, Iran—a major Iranian center for stem cell research and regenerative medicine. Researchers from Tehran University of Medical Sciences, Iran University of Medical Sciences, and the University of Science […]
What Was Studied The author analyzed the accumulated data on the use of mesenchymal stromal/stem cells (MSCs) in type 2 diabetes, including preclinical studies and early clinical trials conducted between approximately 2000 and 2025.The focus is on several potential mechanisms of action of MSCs: immunomodulation and reduction of chronic inflammation, paracrine secretion of bioactive factors, […]
Україна, Київ вул.Володимирська 11
+38 (099) 111-22-33
info@gmail.com
Графік роботи: 9:00 – 17:00
Субота 09:00 – 13:00
